Australia's Immuron hits over 2-month high on robust global sales

Hanall Biopharma

27/04/2022 02:40

** Shares of the biopharma co  IMC.AX  rise as much as 8.7%
to A$0.125, their highest since Feb 16 
    ** Immuron says global sales in the third quarter were up
216% YOY  urn:newsml:reuters.com:*:nASX2ds3yP
    ** Adds that FY22 worldwide sales of digestive health immune
supplement Travelan increased 340% YoY
    ** Shares on track for their biggest intraday pct gain since
April 19
    ** More than 561,200 shares change hands as compared with
the 30-day average volume of ~254,000 shares  
    ** Stock has risen 15% this year, as of last close, vs a
2.7% decrease in the S&P/ASX 200 index  .AXJO  


 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))